Linden Thomas Advisory Services LLC Lowers Stock Position in National Research Co. (NASDAQ:NRC)

Linden Thomas Advisory Services LLC trimmed its holdings in National Research Co. (NASDAQ:NRC) by 1.7% during the fourth quarter, HoldingsChannel.com reports. The fund owned 27,164 shares of the company’s stock after selling 479 shares during the period. Linden Thomas Advisory Services LLC’s holdings in National Research were worth $1,075,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently bought and sold shares of the company. iA Global Asset Management Inc. purchased a new position in National Research during the 3rd quarter worth $11,124,000. Charles Schwab Investment Management Inc. grew its holdings in shares of National Research by 4.6% during the third quarter. Charles Schwab Investment Management Inc. now owns 111,434 shares of the company’s stock worth $4,944,000 after buying an additional 4,895 shares during the last quarter. Swiss National Bank increased its position in National Research by 1.6% in the 3rd quarter. Swiss National Bank now owns 32,500 shares of the company’s stock valued at $1,442,000 after acquiring an additional 500 shares during the period. Comerica Bank purchased a new stake in National Research during the 3rd quarter valued at approximately $6,939,000. Finally, Cardinal Capital Management lifted its position in National Research by 3.0% during the 4th quarter. Cardinal Capital Management now owns 16,525 shares of the company’s stock worth $656,000 after acquiring an additional 483 shares during the period. Hedge funds and other institutional investors own 47.26% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, TheStreet lowered National Research from a “b-” rating to a “c+” rating in a report on Thursday, January 11th.

National Research Stock Up 0.1 %

Shares of National Research stock opened at $34.27 on Thursday. National Research Co. has a one year low of $32.08 and a one year high of $47.25. The company has a market cap of $817.34 million, a P/E ratio of 27.42 and a beta of 0.42. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.67 and a current ratio of 0.67. The firm has a fifty day moving average of $38.39 and a two-hundred day moving average of $39.88.

National Research (NASDAQ:NRC) last posted its quarterly earnings results on Tuesday, February 13th. The company reported $0.36 earnings per share (EPS) for the quarter. National Research had a net margin of 20.84% and a return on equity of 47.79%. The firm had revenue of $38.00 million during the quarter.

National Research Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Friday, March 29th were issued a $0.12 dividend. The ex-dividend date of this dividend was Wednesday, March 27th. This represents a $0.48 annualized dividend and a dividend yield of 1.40%. National Research’s dividend payout ratio is currently 38.40%.

National Research Company Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.